Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Furiex Pharmaceuticals, Inc. (FURX) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Furiex Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1484478.
Total stock buying since 2014: $1,061,061,270.
Total stock sales since 2014: $17,716,915.
Total stock option exercises since 2014: $1,784,392.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2014 | 11,169,066 | $1,061,061,270 | 169,544 | $17,716,915 | 159,640 | $1,784,392 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2014-07 | 11,169,066 | $1,061,061,270 | 0 | $0 | 0 | $0 |
| 2014-06 | 0 | $0 | 169,544 | $17,716,915 | 159,640 | $1,784,392 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-07-02 | Actavis Plc (10% Owner) | Buy | 11,169,066 | 95.00 | 1,061,061,270 |
| 2014-06-24 | Patel Sailash (Chief Financial Officer) | Sale | 32,928 | 104.00 | 3,424,512 |
| 2014-06-24 | Patel Sailash (Chief Financial Officer) | Option Ex | 32,928 | 9.11 | 299,974 |
| 2014-06-24 | Covington Paul S (Senior VP-Clinical Operations) | Sale | 10,368 | 104.12 | 1,079,516 |
| 2014-06-24 | Covington Paul S (Senior VP-Clinical Operations) | Option Ex | 10,368 | 17.80 | 184,550 |
| 2014-06-18 | Covington Paul S (Senior VP-Clinical Operations) | Sale | 45,691 | 104.11 | 4,756,890 |
| 2014-06-18 | Covington Paul S (Senior VP-Clinical Operations) | Option Ex | 45,691 | 9.11 | 416,245 |
| 2014-06-17 | Mcintyre Gail Frances (Senior Vice President-Research) | Sale | 8,008 | 105.00 | 840,840 |
| 2014-06-17 | Mcintyre Gail Frances (Senior Vice President-Research) | Option Ex | 8,008 | 13.16 | 105,385 |
| 2014-06-16 | Mcintyre Gail Frances (Senior Vice President-Research) | Sale | 66,449 | 105.02 | 6,978,141 |
| 2014-06-16 | Mcintyre Gail Frances (Senior Vice President-Research) | Option Ex | 62,645 | 12.42 | 778,238 |
| 2014-06-13 | Covington Paul S (Senior VP-Clinical Operations) | Sale | 3,228 | 104.25 | 336,519 |
| 2014-06-10 | Covington Paul S (Senior VP-Clinical Operations) | Sale | 2,872 | 104.63 | 300,497 |
Insider trading activities including stock purchases, stock sales, and option exercises of FURX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Furiex Pharmaceuticals, Inc. (symbol FURX, CIK number 1484478) see the Securities and Exchange Commission (SEC) website.